ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020
A Review of Measles Outbreak Cost Estimates From the United States in the Postelimination Era (2004-2017): Estimates by Perspective and Cost Type.
Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Cost of a Measles Outbreak in an Urban Shelter.JAMA network open · 2026Article
- Characteristics of Patients Hospitalized with Measles During an Outbreak - West Texas, January-March 2025.MMWR. Morbidity and mortality weekly report · 2026Article
- The health and economic repercussions of declining MMR coverage in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Ensuring respiratory protection to improve population health, economic vitality, and national security.Lancet regional health. Americas · 2025Review
- Economic value of pre-travel health interventions for communicable diseases in international travellers.Journal of travel medicine · 2025Review
- Clinical and epidemiological characteristics of the 2024-2025 measles outbreak in Sarajevo Canton.European journal of epidemiology · 2025Article
- Performance Metrics for Measles Response Optimization in the United States: Considerations for Public Health Research, Policy, and Practice.Public health reports (Washington, D.C. : 1974) · 2025Article
- The Continued Risk of Measles Outbreaks in the United States Resulting From Suboptimal Vaccination Coverage.Public health reports (Washington, D.C. : 1974) · 2025Article
- The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination.Vaccines · 2024Article
- Measles resurgence in Armenia: unmasking health system vulnerabilities and crafting comprehensive eradication strategies - a review.Annals of medicine and surgery (2012) · 2024Review
- Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics.Vaccines · 2024Review
- Notes from the Field: Measles Outbreak - Cook County, Illinois, October-November 2023.MMWR. Morbidity and mortality weekly report · 2024Article
- Article
- Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2024Article
- Measles and Varicella Vaccination Program in a Hospital: Implementation and Impact on Contact Tracing.Vaccines · 2023Article
- Virus-Associated Nephropathies: A Narrative Review.International journal of molecular sciences · 2022Review
- Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination.The Journal of infectious diseases · 2021Article
- Vaccine-Associated Measles in a Hematopoietic Cell Transplant Recipient: Case Report and Comprehensive Review of the Literature.Open forum infectious diseases · 2021Article
- Societal Costs of a Measles Outbreak.Pediatrics · 2021Article
- Inadequate Measles, Mumps, Rubella, and Varicella Immunity Among Employees.Journal of primary care & community healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Despite the elimination of measles in the United States (US) in the year 2000, cases continue to occur, with measles outbreaks having occurred in various jurisdictions in the US in 2018 and 2019. Understanding the cost associated with measles outbreaks can inform cost-of-illness and cost-effectiveness studies of measles and measles prevention. We performed a literature review and identified 10 published studies from 2001 through 2018 that presented cost estimates from 11 measles outbreaks. The median total cost per measles outbreak was $152 308 (range, $9862-$1 063 936); the median cost per case was $32 805 (range, $7396-$76 154) and the median cost per contact was $223 (range, $81-$746). There were limited data on direct and indirect costs associated with measles. These findings highlight how costly measles outbreaks can be, the value of this information for public health department budgeting, and the importance of more broadly documenting the cost of measles outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.